358 related articles for article (PubMed ID: 32289231)
1. Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality.
Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Lange P
Am J Respir Crit Care Med; 2020 Jul; 202(2):210-218. PubMed ID: 32289231
[No Abstract] [Full Text] [Related]
2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
[No Abstract] [Full Text] [Related]
3. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
4. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.
Lange P; Celli B; Agustí A; Boje Jensen G; Divo M; Faner R; Guerra S; Marott JL; Martinez FD; Martinez-Camblor P; Meek P; Owen CA; Petersen H; Pinto-Plata V; Schnohr P; Sood A; Soriano JB; Tesfaigzi Y; Vestbo J
N Engl J Med; 2015 Jul; 373(2):111-22. PubMed ID: 26154786
[TBL] [Abstract][Full Text] [Related]
5. A Distinct Low Lung Function Trajectory from Childhood to the Fourth Decade of Life.
Berry CE; Billheimer D; Jenkins IC; Lu ZJ; Stern DA; Gerald LB; Carr TF; Guerra S; Morgan WJ; Wright AL; Martinez FD
Am J Respir Crit Care Med; 2016 Sep; 194(5):607-12. PubMed ID: 27585385
[TBL] [Abstract][Full Text] [Related]
6. Ratio of FEV
Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.
Prats E; Tejero E; Pardo P; Gavilán A; Galera R; Donado JR; Racionero MÁ; Casitas R; Zapatero A; García-Río F
PLoS One; 2015; 10(10):e0140855. PubMed ID: 26489023
[TBL] [Abstract][Full Text] [Related]
9. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.
Bui DS; Lodge CJ; Burgess JA; Lowe AJ; Perret J; Bui MQ; Bowatte G; Gurrin L; Johns DP; Thompson BR; Hamilton GS; Frith PA; James AL; Thomas PS; Jarvis D; Svanes C; Russell M; Morrison SC; Feather I; Allen KJ; Wood-Baker R; Hopper J; Giles GG; Abramson MJ; Walters EH; Matheson MC; Dharmage SC
Lancet Respir Med; 2018 Jul; 6(7):535-544. PubMed ID: 29628376
[TBL] [Abstract][Full Text] [Related]
10. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
[TBL] [Abstract][Full Text] [Related]
11. Lung function decline and outcomes in an elderly population.
Mannino DM; Davis KJ
Thorax; 2006 Jun; 61(6):472-7. PubMed ID: 16517577
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
[TBL] [Abstract][Full Text] [Related]
14. Female reproductive history in relation to chronic obstructive pulmonary disease and lung function in UK biobank: a prospective population-based cohort study.
Tang R; Fraser A; Magnus MC
BMJ Open; 2019 Oct; 9(10):e030318. PubMed ID: 31662371
[TBL] [Abstract][Full Text] [Related]
15. Per cent low attenuation volume and fractal dimension of low attenuation clusters on CT predict different long-term outcomes in COPD.
Shimizu K; Tanabe N; Tho NV; Suzuki M; Makita H; Sato S; Muro S; Mishima M; Hirai T; Ogawa E; Nakano Y; Konno S; Nishimura M
Thorax; 2020 Feb; 75(2):116-122. PubMed ID: 31896733
[TBL] [Abstract][Full Text] [Related]
16. Lung Function Trajectories and Associated Mortality among Adults with and without Airway Obstruction.
Backman H; Blomberg A; Lundquist A; Strandkvist V; Sawalha S; Nilsson U; Eriksson-Ström J; Hedman L; Stridsman C; Rönmark E; Lindberg A
Am J Respir Crit Care Med; 2023 Nov; 208(10):1063-1074. PubMed ID: 37460250
[No Abstract] [Full Text] [Related]
17. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
[TBL] [Abstract][Full Text] [Related]
18. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG
Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717
[TBL] [Abstract][Full Text] [Related]
19. FEV1 is a better predictor of mortality than FVC: the PLATINO cohort study.
Menezes AM; Pérez-Padilla R; Wehrmeister FC; Lopez-Varela MV; Muiño A; Valdivia G; Lisboa C; Jardim JR; de Oca MM; Talamo C; Bielemann R; Gazzotti M; Laurenti R; Celli B; Victora CG;
PLoS One; 2014; 9(10):e109732. PubMed ID: 25285441
[TBL] [Abstract][Full Text] [Related]
20. Blood biomarkers as predictors of long-term mortality in COPD.
Mendy A; Forno E; Niyonsenga T; Gasana J
Clin Respir J; 2018 May; 12(5):1891-1899. PubMed ID: 29227024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
